# Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

> **NCT06205121** · PHASE2 · RECRUITING · sponsor: **Molecure S.A.** · enrollment: 96 (estimated)

## Conditions studied

- Pulmonary Sarcoidosis

## Interventions

- **DRUG:** OATD-01
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06205121
- **Lead sponsor:** Molecure S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-03-21
- **Primary completion:** 2027-08
- **Final completion:** 2027-09
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06205121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06205121, "Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT06205121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*